+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Gastrointestinal Market, Forecast to 2029

  • PDF Icon


  • 149 Pages
  • January 2022
  • Region: Global
  • Infinity Business Insights
  • ID: 5582348
This report focuses on the Gastrointestinal market revenue at the global, regional, and company levels. From a global perspective, this report represents overall Gastrointestinal market size by analyzing historical data and future prospects. The review gives an inside and out the investigation of the worldwide gastrointestinal market with the latest innovations and future assessments to clarify unavoidable venture pockets. Regionally, this report focuses on several key regions: North America, Europe, Asia Pacific, South America, the Middle East, and Africa.

Key Points Covered in the Report

  • Market Revenue of the Gastrointestinal Market from 2017 to 2029.
  • Market Forecast for the Gastrointestinal Market from 2021 to 2029.
  • Regional Market Share and revenue from 2017 to 2029.
  • Country Market share within the region from 2017 to 2029.
  • Key Drug Class and Route of Administration revenue and forecast.
  • Company Market Share Analysis, competitive scenario, ranking, and detailed company profiles.
  • Market driver, restraints, and detailed COVID-19 impact on Gastrointestinal Market.

The top players in the market are Takeda Pharmaceutical, Valeant Pharmaceuticals, Nestlé, AstraZeneca, Bayer AG, Janssen CarePath, Abbott Laboratories, Boehringer Ingelheim, and Others

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • Nestlé
  • AstraZeneca
  • Bayer AG
  • Janssen CarePath
  • Abbott Laboratories
  • Boehringer Ingelheim